Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 12.41
-0.65 (-4.98%)
Apr 30, 2025, 3:00 PM CST
SHA:605199 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Revenue | 1,861 | 1,905 | 1,515 | 1,354 | 1,162 | 1,306 | Upgrade
|
| Revenue Growth (YoY) | 7.18% | 25.75% | 11.91% | 16.54% | -11.04% | 32.75% | Upgrade
|
| Cost of Revenue | 844.27 | 907.79 | 644.31 | 546.54 | 444.38 | 498.09 | Upgrade
|
| Gross Profit | 1,017 | 997.39 | 870.74 | 807.25 | 717.33 | 807.83 | Upgrade
|
| Selling, General & Admin | 751.12 | 734.51 | 654.11 | 612.94 | 541.56 | 615.11 | Upgrade
|
| Research & Development | 130.02 | 93.92 | 105.66 | 100.43 | 51.66 | 51.66 | Upgrade
|
| Other Operating Expenses | 2.28 | 16.84 | 13.68 | 17.95 | 13.37 | 15.31 | Upgrade
|
| Operating Expenses | 909.86 | 867.18 | 773.21 | 734.55 | 616.78 | 686.59 | Upgrade
|
| Operating Income | 106.99 | 130.21 | 97.52 | 72.7 | 100.55 | 121.24 | Upgrade
|
| Interest Expense | -24.92 | -18.24 | -18 | -13.87 | -9.1 | -13.36 | Upgrade
|
| Interest & Investment Income | 13.85 | 1.34 | 2.01 | 3.77 | 0.88 | 2.43 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | -1.34 | -1.08 | 0.02 | 0.06 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | 96.03 | 111.97 | 80.45 | 62.62 | 92.39 | 110.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.03 | -4.43 | -2.06 | -3.66 | -0.49 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.11 | -0.08 | -0.55 | -0.47 | -0.21 | -0.02 | Upgrade
|
| Asset Writedown | -1.44 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 27.31 | 28.04 | 19.38 | 23.18 | 42.7 | 32.05 | Upgrade
|
| Pretax Income | 121.83 | 135.49 | 97.23 | 81.66 | 134.39 | 142.24 | Upgrade
|
| Income Tax Expense | 5.49 | 22.87 | 12.49 | 12.11 | 12.89 | 21.91 | Upgrade
|
| Earnings From Continuing Operations | 116.33 | 112.62 | 84.74 | 69.56 | 121.5 | 120.33 | Upgrade
|
| Minority Interest in Earnings | -5.06 | -6.12 | 0.94 | 2.58 | - | - | Upgrade
|
| Net Income | 111.27 | 106.5 | 85.68 | 72.14 | 121.5 | 120.33 | Upgrade
|
| Net Income to Common | 111.27 | 106.5 | 85.68 | 72.14 | 121.5 | 120.33 | Upgrade
|
| Net Income Growth | 21.88% | 24.29% | 18.77% | -40.63% | 0.97% | 19.68% | Upgrade
|
| Shares Outstanding (Basic) | 382 | 394 | 408 | 401 | 380 | 365 | Upgrade
|
| Shares Outstanding (Diluted) | 382 | 394 | 408 | 401 | 380 | 365 | Upgrade
|
| Shares Change (YoY) | -7.74% | -3.33% | 1.81% | 5.55% | 4.13% | 12.43% | Upgrade
|
| EPS (Basic) | 0.29 | 0.27 | 0.21 | 0.18 | 0.32 | 0.33 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.27 | 0.21 | 0.18 | 0.32 | 0.33 | Upgrade
|
| EPS Growth | 32.10% | 28.57% | 16.67% | -43.75% | -3.03% | 6.45% | Upgrade
|
| Free Cash Flow | -150.22 | -460.95 | -153.61 | -35.14 | -56.12 | 86.12 | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -1.17 | -0.38 | -0.09 | -0.15 | 0.24 | Upgrade
|
| Dividend Per Share | 0.125 | 0.125 | - | - | 0.150 | 0.225 | Upgrade
|
| Dividend Growth | - | - | - | - | -33.33% | - | Upgrade
|
| Gross Margin | 54.64% | 52.35% | 57.47% | 59.63% | 61.75% | 61.86% | Upgrade
|
| Operating Margin | 5.75% | 6.83% | 6.44% | 5.37% | 8.65% | 9.28% | Upgrade
|
| Profit Margin | 5.98% | 5.59% | 5.66% | 5.33% | 10.46% | 9.21% | Upgrade
|
| Free Cash Flow Margin | -8.07% | -24.19% | -10.14% | -2.60% | -4.83% | 6.59% | Upgrade
|
| EBITDA | 162.64 | 181.83 | 143.77 | 117.46 | 144.06 | 162.75 | Upgrade
|
| EBITDA Margin | 8.74% | 9.54% | 9.49% | 8.68% | 12.40% | 12.46% | Upgrade
|
| D&A For EBITDA | 55.65 | 51.62 | 46.25 | 44.76 | 43.51 | 41.51 | Upgrade
|
| EBIT | 106.99 | 130.21 | 97.52 | 72.7 | 100.55 | 121.24 | Upgrade
|
| EBIT Margin | 5.75% | 6.83% | 6.44% | 5.37% | 8.65% | 9.28% | Upgrade
|
| Effective Tax Rate | 4.51% | 16.88% | 12.84% | 14.83% | 9.59% | 15.40% | Upgrade
|
| Revenue as Reported | 1,861 | 1,905 | 1,515 | 1,354 | 1,162 | 1,306 | Upgrade
|
| Advertising Expenses | - | 472.55 | 452.11 | 426.22 | 401.89 | 453.5 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.